Imuniti Holdings Limited (“IMU”), a listed company on the Johannesburg Stock Exchange during December 2006, was founded by the founder members of the Edge2Edge Group as a vehicle for the South African roll-out. Imuniti Holdings purchased a non exclusive manufacturing license for the region of South Africa from Edge2Edge Global. Edge2Edge Global is a major share holder in Imuniti Holding Ltd

.
Imuniti Holdings holds 100% share in  Impilo Drugs that manufacture natural, complementary and pharmaceutical products and Nutritional Foods that manufacture high protein and fortified nutritional powdered foodstuffs. IMU manufactures and markets the Imuniti Nutritional Supplement Combo pack under license for the South Africa market.

Nutritional Foods, currently one of the largest producers of dry blended products in South Africa, is situated in Klerksdorp and facilities at the plant include packaging, warehousing and delivery systems. The extensive range of catering products is used by large-scale industrial food users such as contract catering companies, mining houses, schools, colleges, feeding schemes, prison services, hospitals and wholesalers. Pack sizes are designed for economics of scale and are also suitable for use by specialist retail outlets such as agricultural co-ops. (See more on Nutritional foods below)

Impilo, established in the 1940s, manufactures its own generic drugs and complementary medicines. Impilo manufactures around 382 formulas. The potential capacity of the Impilo factory is 60 million tablets, 10 million capsules and 150 kiloliters of liquids and ointment per month. Impilo is a registered Medicines Control Council (MCC) facility and manufactures its products according to Good Manufacturing Practice (“GMP”) standards. (See more on Impilo Drugs below)